The efficacy and safety of venetoclax combined with demethylating agents in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis

CONCLUSIONS: The combination of venetoclax and demethylating drugs has a good therapeutic effect on elderly patients with acute myeloid leukemia, but it also induces some adverse events. Although this therapy has a small impact on the quality of life, further attention is still needed to reduce the occurrence of such adverse events.PMID:38497866 | DOI:10.26355/eurrev_202403_35597

Source: Pharmacological Reviews - March 18, 2024 Category: Drugs & Pharmacology Authors: M-Y Wei J Yin Y Liao J-Y Liu Y Zhao X-M Chen Y Liu X-M Wang C-L Huang Source Type: research